JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.65B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.08B |
| 3 |
Microsoft
MSFT
|
+$2.05B |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$1.64B |
| 5 |
Micron Technology
MU
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$2.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.11B |
| 3 |
Progressive
PGR
|
+$1.64B |
| 4 |
Salesforce
CRM
|
+$1.54B |
| 5 |
Adobe
ADBE
|
+$1.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Technology | 24.03% |
| 3 | Healthcare | 9.24% |
| 4 | Consumer Discretionary | 8.79% |
| 5 | Financials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3051
JPMorgan BetaBuilders USD Investment Grade Corporate Bond ETF
BBCB
$50.3M
| $4.25M | ﹤0.01% |
94,770
-13,487
| -12% | -$603K |
2018 Q4
22 quarters
|
|
3052
International Money Express
IMXI
$348M
| $4.24M | ﹤0.01% |
203,657
+49,581
| +32% | +$1.04M |
2019 Q1
21 quarters
|
|
3053
Zai Lab
ZLAB
$2.73B
| $4.24M | ﹤0.01% |
244,522
+200,600
| +457% | +$3.53M |
2020 Q1
17 quarters
|
|
3054
Coeur Mining
CDE
$18.2B
| $4.23M | ﹤0.01% |
753,264
+308,140
| +69% | +$1.59M |
2013 Q2
44 quarters
|
|
3055
Cellebrite
CLBT
$2.78B
| $4.21M | ﹤0.01% |
352,563
+120,519
| +52% | +$1.35M |
2021 Q3
11 quarters
|
|
3056
Invesco S&P 500 Pure Growth ETF
RPG
$1.96B
| $4.21M | ﹤0.01% |
113,015
-15,752
| -12% | -$563K |
2013 Q2
44 quarters
|
|
3057
CALL
Moody's
MCO
$76.4B
| $4.21M | ﹤0.01% |
10,000
| – | – |
2024 Q1
1 quarter
|
|
3058
CALL
Globe Life
GL
$12.7B
| $4.2M | ﹤0.01% |
+51,100
| New | +$4.23M |
2024 Q2
0 quarters
|
|
|
VSTO
3059
DELISTED
Vista Outdoor Inc.
VSTO
| $4.2M | ﹤0.01% |
111,421
-73,674
| -40% | -$2.54M |
2015 Q1
37 quarters
|
|
3060
Utah Medical Products
UTMD
$235M
| $4.19M | ﹤0.01% |
62,766
-9,786
| -13% | -$666K |
2015 Q3
35 quarters
|
|
3061
CALL
Autodesk
ADSK
$44.3B
| $4.18M | ﹤0.01% |
16,900
| – | – |
2023 Q3
3 quarters
|
|
3062
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
$2.61B
| $4.18M | ﹤0.01% |
90,758
+8,099
| +10% | +$371K |
2023 Q3
3 quarters
|
|
3063
LegalZoom.com
LZ
$959M
| $4.16M | ﹤0.01% |
496,384
+75,547
| +18% | +$778K |
2021 Q2
12 quarters
|
|
3064
Universal Corp
UVV
$1.05B
| $4.15M | ﹤0.01% |
86,171
+12,302
| +17% | +$614K |
2013 Q2
44 quarters
|
|
3065
BlackBerry
BB
$5.46B
| $4.15M | ﹤0.01% |
1,671,722
-483,665
| -22% | -$1.35M |
2013 Q2
44 quarters
|
|
3066
RXO
RXO
$3.86B
| $4.14M | ﹤0.01% |
158,377
-131,272
| -45% | -$2.73M |
2022 Q4
6 quarters
|
|
|
REVG
3067
DELISTED
REV Group
REVG
| $4.13M | ﹤0.01% |
166,116
-197,208
| -54% | -$4.84M |
2017 Q3
27 quarters
|
|
3068
CALL
Neurocrine Biosciences
NBIX
$14.6B
| $4.13M | ﹤0.01% |
+30,000
| New | +$4.11M |
2024 Q2
0 quarters
|
|
|
3069
PUT
Neurocrine Biosciences
NBIX
$14.6B
| $4.13M | ﹤0.01% |
+30,000
| New | +$4.11M |
2024 Q2
0 quarters
|
|
3070
Harmony Biosciences
HRMY
$2.31B
| $4.13M | ﹤0.01% |
136,806
+93,967
| +219% | +$2.83M |
2020 Q3
15 quarters
|
|
3071
PUT
IQVIA
IQV
$42.5B
| $4.12M | ﹤0.01% |
+19,500
| New | +$4.43M |
2024 Q2
0 quarters
|
|
3072
Red Rock Resorts
RRR
$2.97B
| $4.12M | ﹤0.01% |
75,049
+21,288
| +40% | +$1.16M |
2016 Q2
32 quarters
|
|
3073
CALL
Honeywell
HON
$67.8B
| $4.12M | ﹤0.01% |
20,477
-13,475
| -40% | -$2.56M |
2021 Q2
12 quarters
|
|
3074
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$11B
| $4.12M | ﹤0.01% |
123,345
-19,254
| -14% | -$648K |
2022 Q4
6 quarters
|
|
3075
Ingevity
NGVT
$2.49B
| $4.11M | ﹤0.01% |
94,121
-137,814
| -59% | -$6.66M |
2016 Q2
32 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2024 Portfolio in Review
As of Q2 2024, JP Morgan Chase held 7,917 positions worth $1.22T, up 3% from $1.18T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q2 2024 filing shows 549 new, 2,506 increased, 3,286 reduced and 578 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2024 buy was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M.
- JP Morgan Chase added most to Apple in Q2 2024, an estimated $4.65B increase.
- JP Morgan Chase's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.11B.
- JP Morgan Chase fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $2.4B.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.22T portfolio in Q2 2024.
- JP Morgan Chase opened 549 new positions and closed 578 in Q2 2024.
- JP Morgan Chase's portfolio value rose 3% quarter-over-quarter to $1.22T.
Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.